InvestorNewsBreaks – TC BioPharm Holdings PLC (NASDAQ: TCBP) to Be Delisted, Will Move to OTC Markets
TC BioPharm (NASDAQ: TCBP), a clinical-stage biotech company focused on allogeneic gamma-delta T cell therapies, announced it will be delisted from the Nasdaq Stock Market following a determination by the Nasdaq Hearings Panel. The decision, dated March 20, 2025, stems from the company's failure to meet the minimum $1.00 bid price required under Rule 5550(a)(2). Trading on Nasdaq will be suspended at the opening on…